Development of novel therapy targeting dendritic cells for Crohn's disease

开发针对克罗恩病的树突状细胞新疗法

基本信息

  • 批准号:
    15590685
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Crohn's disease(CD) is a chronic inflammatory process involving the gastrointestinal tract, characterised by discontinuous and transmural inflammation. Although the etiology of CD is not fully understood, accumulating evidence suggests that dysregulation of the local immune system is pivotal in the pathogenesis of CD. Studies from humans and experimental murine colitis models indicate that in CD, the local immune response tends to be predominantly T helper cell type 1(Th1) and is reflected by local release of cytokines such as tumor necrosis factor (TNF)-□, interleukin (IL)-12, and IL-18. However, it has not been elucidated what triggers the Th1 immune response in CD. In the present study, we attempted to establish the purification of dendrtic cells from mesenteric lymph nodes(MLN) and to analyze the immune cascade in the mesenteric lymph nodes of human CD.We established the purification of dendrtic cells from MLN by density gradient centrifugation and immunomagnetic depletion of CD3^+,CD11b^+ and CD16^+ cells followed by positive isolation with CD4^+. The analysis of cells obtained from MLNs revealed that the proportion of DC1 was increased in the MLN of CD compared to ulcerative colitis and control and that CD4+ T lymphocytes from the MLN of CD show a Th1 profile.This is the first study to report the characterization of MLN dendritic cells and cytokine profiles of the MLN CD4+ T cells from human IBD patients. This study shows that MLN dendritic cells have considerable effects in the pathogenesis of IBD. The MLN may be the place where the dysregulated immune responses, such as Th1 in CD, first occur.
克罗恩病(CD)是一种累及胃肠道的慢性炎症过程,其特征为不连续和透壁炎症。虽然CD的病因尚未完全清楚,但越来越多的证据表明,局部免疫系统的失调在CD的发病机制中至关重要。来自人类和实验鼠结肠炎模型的研究表明,在CD中,局部免疫应答倾向于主要是T辅助细胞1型(Th 1),并通过局部释放细胞因子(如肿瘤坏死因子(TNF)-□、白细胞介素(IL)-12和IL-18)反映。然而,还没有阐明是什么触发CD中的Th 1免疫应答。本研究采用密度梯度离心、免疫磁珠法去除CD 3 ^+、CD 11b ^+和CD 16 ^+细胞,再用CD 4 ^+细胞进行阳性分离,建立了从人CD肠系膜淋巴结(MLN)中分离纯化树突状细胞的方法,并对MLN中的免疫级联反应进行了分析。从MLN获得的细胞的分析显示,DC 1的比例增加,在MLN的CD相比,溃疡性结肠炎和控制和CD的MLN的CD 4 + T淋巴细胞显示Th 1 profile.This是第一个研究报告MLN树突状细胞和MLN的CD 4 + T细胞的细胞因子谱从人类IBD患者的表征。本研究表明MLN树突状细胞在IBD的发病机制中具有重要作用。MLN可能是失调的免疫应答(如CD中的Th 1)首先发生的地方。

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Thi immune response.
克罗恩病中骨桥蛋白/Eta-1 上调可调节 Thi 免疫反应。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sato T;Nakai T;Tamura N;Okamoto S;Matsuoka K;Sakuraba A;Fukushima T;Uede T;Hibi T
  • 通讯作者:
    Hibi T
T-bet up-regulation and subsequent interleukin 12 stimulation are essential for the induction of Th1 mediated immunopathology in Croha's disease.
T-bet 上调和随后的白细胞介素 12 刺激对于克罗哈病中 Th1 介导的免疫病理学的诱导至关重要。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matsuoka K;Inoue N;Sato T;Okamoto S;Hisamatsu T;Kishi Y;Sakuraba A;Hitotsumatsu O;Fukushima T;Kanai T;Watanabe M;Ishii H;Hibi T
  • 通讯作者:
    Hibi T
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response
  • DOI:
    10.1136/gut.2004.048298
  • 发表时间:
    2005-09-01
  • 期刊:
  • 影响因子:
    24.5
  • 作者:
    Sato, T;Nakai, T;Hibi, T
  • 通讯作者:
    Hibi, T
Hyperexpression of inducible costimulator its contribution on lamina propria T cells in inflammatory bowel disease.
诱导共刺激物的过度表达及其对炎症性肠病固有层 T 细胞的贡献。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sato T;Hibi T;et al.
  • 通讯作者:
    et al.
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease
  • DOI:
    10.1053/j.gastro.2003.12.011
  • 发表时间:
    2004-03-01
  • 期刊:
  • 影响因子:
    29.4
  • 作者:
    Sato, T;Kanai, T;Hibi, T
  • 通讯作者:
    Hibi, T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IWAO Yasushi其他文献

IWAO Yasushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IWAO Yasushi', 18)}}的其他基金

Research of Inflammatory Bowel Disease Based on Clinical Immunology and Endoscopy
基于临床免疫学和内镜检查的炎症性肠病研究
  • 批准号:
    23590949
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of cancer surveillance using serum anti-p53 antibody in patients with ulcerative colitis
使用溃疡性结肠炎患者血清抗 p53 抗体建立癌症监测
  • 批准号:
    20590748
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel therapy targeting innate immunity for Crohn's disease
针对克罗恩病先天免疫的新疗法的开发
  • 批准号:
    17590678
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidating type 1 conventional dendritic cell-dependent anti-tumour immune responses in brain metastases
阐明脑转移瘤中 1 型传统树突状细胞依赖性抗肿瘤免疫反应
  • 批准号:
    MR/Y013328/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
浆细胞样树突状细胞发育和功能的分子控制
  • 批准号:
    10583989
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Intestinal Microbiota Affect Stroke Outcome by Modulating the Dendritic Cell-regulatory T Cell Axis
肠道微生物群通过调节树突状细胞调节 T 细胞轴影响中风结果
  • 批准号:
    10751249
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
The Effect Of Malaria Parasites On Dendritic Cell Metabolism (TEMPODM)
疟原虫对树突状细胞代谢的影响 (TEMPODM)
  • 批准号:
    BB/X00029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
转移部位对树突状细胞驱动的肿瘤免疫的影响
  • 批准号:
    10738428
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Probing the effect of dendritic cell co-stimulatory ligand lateral mobility on T cell mediated immunity and tolerance
探讨树突状细胞共刺激配体横向移动对T细胞介导的免疫和耐受的影响
  • 批准号:
    BB/X015408/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
Dendritic cell targeting by bacterial LysM proteins to suppress inflammation
树突状细胞通过细菌 LysM 蛋白靶向抑制炎症
  • 批准号:
    10750594
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Induced pluripotent stem cell-derived dendritic cell vaccine therapy genetically modified to express neo-antigen
诱导多能干细胞衍生的树突状细胞疫苗疗法经过基因改造以表达新抗原
  • 批准号:
    23K08160
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System
通过新型混合生物-生物材料载体系统进行靶向基因递送和人类树突状细胞成熟
  • 批准号:
    10586414
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Role of glutamine metabolism in Dendritic Cell Development
谷氨酰胺代谢在树突状细胞发育中的作用
  • 批准号:
    10735230
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了